Medip, IJRCOG-4746 O
Medip, IJRCOG-4746 O
Medip, IJRCOG-4746 O
DOI: http://dx.doi.org/10.18203/2320-1770.ijrcog20182447
Original Research Article
Principal, College of Nursing, Rajendra Institute of Medical Sciences, RIMS, Ranchi, Jharkhand, India
*Correspondence:
Dr. Prabha Dey,
E-mail: [email protected]
Copyright: © the author(s), publisher and licensee Medip Academy. This is an open-access article distributed under
the terms of the Creative Commons Attribution Non-Commercial License, which permits unrestricted non-commercial
use, distribution, and reproduction in any medium, provided the original work is properly cited.
ABSTRACT
Background: Polycystic ovary syndrome (PCOS), also known as hyper androgenic anovolation (HA or Stein-
Leventhal syndrome) is a well-recognised and common condition that causes considerable morbidity. The objective
of the present study was to find out the quality of life of women with polycystic ovarian syndrome.
Methods: Patients with PCOD diagnosed clinically at out patients department were selected for the study. SF 36 was
applied to find out the Quality of life of women with polycystic ovarian syndrome.
Results: A total of 84 patients were participated and 75% of the sample were student, 56.7% were graduate and
86.7% were non-vegetarian. The mean height of the sample was 155±4.81 centimeters. The mean weight of sample
was 59.35±6.63 kgs and BMI mean was 24.70±3.47. Among 35% the duration of diagnosis was less than one year
and for 65% it was more than one year. Means of the all sub set scores, across shorter and longer duration of being
diagnosed as PCOD were significantly same on t test.
Conclusions: Measured by SF 36, women with poly cystic ovarian disease/symptoms are suffering from significantly
lowered quality of life, but independent of their duration of illness.
International Journal of Reproduction, Contraception, Obstetrics and Gynecology Volume 7 · Issue 7 Page 2587
Dey P. Int J Reprod Contracept Obstet Gynecol. 2018 Jul;7(7):2586-2589
The mean height of the sample was 155±4.81 cm. The consisted upto one year (n=21) and longer duration
mean weight of sample was 59.35±6.63 kgs and BMI defined as more than one year (n=39). Means of the all
mean was 24.70±3.47 (kg/m2) (Table 2). sub set scoring across in between shorter and longer
duration of being diagnosed as PCOD. The both groups
For the comparison of SF 36 subset across shorter and showed compromised QOL but there was there was no
longer duration of PCOD diagnosis, the shorter duration statistically significant difference (Table 3).
Table 3: Comparison of SF 36 subset across shorter and longer duration of PCOD diagnosis.
International Journal of Reproduction, Contraception, Obstetrics and Gynecology Volume 7 · Issue 7 Page 2588
Dey P. Int J Reprod Contracept Obstet Gynecol. 2018 Jul;7(7):2586-2589
With the great prevalence of PCOS, and the lack of 7. Naughton MJ, McBee WL. Health‐related quality of
knowledge in the population, many women are set up to life after hysterectomy. Clin Obstet Gynecol. 1997;
struggle with this mysterious disease while feeling 40(4): 947-7.
completely alone. Women with PCOS have also 8. Colwell H, Mathias SD, Pasta DJ, Henning JM and
complained that they have received "less than optimal" Steege JF. A health‐related quality of life instrument
information about the syndrome, including its short and for symptomatic patients with endometriosis: a
long-term implications. It has been also noticed that some validation study. Am J Obstet Gynecol.
of them are really frustrated with her life problems with 1998;179(12):47-55.
menstrual cycle and duration of illness. Because of these 9. Streiner DL, Norman G. Health Measurement Scales:
facts and other research, it had been suggested that A Practical Guide to their Development and Use. 2 nd
information programs for PCOS would be very ed, Oxford University Press, Oxford, UK;2000.
beneficial, especially in the relation to Quality of Life.16 10. Benetti-Pinto CL, Ferreira SR, Antunes A Jr, Yela
DA. The influence of body weight on sexual function
CONCLUSION and quality of life in women with polycystic ovary
syndrome. Arch Gynecol Obstet. 2015;291(2):451-5.
Women with poly cystic ovarian disease / symptoms are 11. Kozak AT, Daviglus ML, Chan C, Kiefe C, Jacobs
suffering from significant impaired quality of life as D, Liu K. Relationship of body mass index in young
measured by HRQOL (SF 36), the impairment was found adulthood and health-related quality of life two
to be independent of their duration of illness. decades later: the Coronary Artery Risk
Development in Young Adults Study. Int J Obestet.
Funding: No funding sources 2011;35(1):134-41.
Conflict of interest: None declared 12. Grivetti L. Psychology and cultural aspects of
Ethical approval: The study was approved by the energy. Nutr Rev. 2001;59(1):5-s12.
Institutional Ethics Committee 13. Clayton WJ, Lipton M, Elford J, Rustin M, Sherr L.
A randomized controlled trial of laser treatment
REFERENCES among hirsute women with polycystic ovary
syndrome. Br J Dermatol. 2005;152(5):986-92.
1. Balen A, Homberg R, Frank S. Defining polycystic 14. Coffey S, Mason H. The effect of polycystic ovary
ovary syndrome. Br Med J. 2009;338:a2968. syndrome on health-related quality of life. Gynecol
2. Sonino N, Fava GA, Mani E. Quality of life of Endocrinol. 2003;17(5):379-86.
hirsute women. Postgrad Med J. 1993, 69(809):186- 15. Coffey S, Bano G, Mason HD. Health-related quality
9. of life in women with polycystic ovary syndrome: a
3. Paulson JD, Haarmann BS, Salerno RL, Asmar P. comparison with the general population using the
An investigation of the relationship between Polycystic Ovary Syndrome Questionnaire (PCOSQ)
emotional maladjustment and infertility. Fertil Steril. and the Short Form-36 (SF-36). Gynecol Endocrinol.
1988, 49(2):258-62. 2006;22(2):80-6.
4. Downey J, Yingling S, McKinney M, Husami N, 16. Ching HL, Burke V, Stuckey BG. Quality of life and
Jewelewicz R, Maidman J. Mood disorders, psychological morbidity in women with polycystic
psychiatric symptoms, and distress in women ovary syndrome: body mass index, age and the
presenting for infertility evaluation. Fertil Steril. provision of patient information are significant
1989;52(3):425-32. modifiers. Clil Endocrinol. 2007;66(3):373-79.
5. Dokras A. Cardiovascular disease risk in women
with PCOS. Steroids. 2013;78(8):773-6.
6. Barry JA, Kuczmierczyk AR, Hardiman PJ. Anxiety Cite this article as: Dey P. Quality of life of women
and depression in polycystic ovary syndrome: a with polycystic ovarian syndrome. Int J Reprod
systematic review and meta-analysis. Hum Reprod. Contracept Obstet Gynecol 2018;7:2586-9.
2011;26(9):2442-51.
International Journal of Reproduction, Contraception, Obstetrics and Gynecology Volume 7 · Issue 7 Page 2589